Individuals Discontinuing Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Than Those on Conventional Diets

Fresh analysis reveals that patients who stop using popular weight-loss injections like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop conventional lifestyle plans.

Findings released in a leading medical journal demonstrates that while overweight individuals can lose a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Users purchasing these medications should be informed of the risk of quick weight regain when the medication concludes," warns expert Dr. Susan Jebb.

This pace of regain suggests a reversion to starting mass within about one and a half years.

Weighing Treatments

The study, which examined dozens of studies involving thousands of patients, contrasted the effects of these new drugs with other pills.

The team emphasize that people who shed pounds through dieting usually experience a more gradual weight regain—approximately 100 grams monthly—post-intervention.

The Reason for the Fast Rebound

Nutrition scientists suggest the mode of action of the drugs accounts for the accelerated rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 concentrations several times higher than normal may cause the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication leads to hunger is uncontrolled, making overeating a significant risk."

An Ongoing Issue?

Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals contend that, considering the high risk of relapse, the treatment is often life-long.

This opinion is echoed by drug manufacturers, who state that the results "underscore the chronic character of excess weight," comparing it to managing diseases like hypertension.

Patient Experiences

People who have stopped the jabs describe a intense return of cravings.

"I experienced a switch flipping and you're instantly starving," described one woman.

The struggle is exacerbated if individuals have not developed sustainable lifestyle or habit changes during therapy.

Growing Adoption

Survey data indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.

• Use is higher among females compared to males.
• The 40s and 50s demographic shows the greatest usage rates.
• Many obtain the drugs through private prescriptions rather than public health services.

In conclusion, clinicians emphasize that while the jabs are potent tools for weight loss, they are not a standalone cure and long-term success likely depends on ongoing lifestyle support.